Fatal veno-occlusive disease of the liver following high dose chemotherapy, irradiation and bone marrow transplantation. 1980

W G Woods, and L P Dehner, and M E Nesbit, and W Krivit, and P F Coccia, and N K Ramsay, and T H Kim, and J H Kersey

In two patients fatal veno-occlusive disease of the liver developed after bone marrow transplantation for underlying malignancies. Both had received significant pretransplant chemotherapy, including cystosine arabinoside, and total body irradiation. The diagnosis of veno-occlusive disease should be considered in patients in whom hepatomegaly, ascites and deteriorating liver function tests develop after they have received cancer chemotherapy.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D011878 Radiotherapy The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions. Radiotherapy, Targeted,Targeted Radiotherapy,Radiation Therapy,Radiation Therapy, Targeted,Radiation Treatment,Targeted Radiation Therapy,Radiation Therapies,Radiation Therapies, Targeted,Radiation Treatments,Radiotherapies,Radiotherapies, Targeted,Targeted Radiation Therapies,Targeted Radiotherapies,Therapies, Radiation,Therapies, Targeted Radiation,Therapy, Radiation,Therapy, Targeted Radiation,Treatment, Radiation
D002051 Burkitt Lymphoma A form of undifferentiated malignant LYMPHOMA usually found in central Africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of Burkitt lymphoma. The Epstein-Barr virus (HERPESVIRUS 4, HUMAN) has been isolated from Burkitt lymphoma cases in Africa and it is implicated as the causative agent in these cases; however, most non-African cases are EBV-negative. African Lymphoma,Burkitt Cell Leukemia,Burkitt Tumor,Lymphoma, Burkitt,Burkitt Leukemia,Burkitt's Leukemia,Burkitt's Lymphoma,Burkitt's Tumor,Leukemia, Lymphoblastic, Burkitt-Type,Leukemia, Lymphocytic, L3,Lymphocytic Leukemia, L3,Burkitts Leukemia,Burkitts Lymphoma,Burkitts Tumor,L3 Lymphocytic Leukemia,L3 Lymphocytic Leukemias,Leukemia, Burkitt,Leukemia, Burkitt Cell,Leukemia, Burkitt's,Leukemia, L3 Lymphocytic,Lymphoma, African,Lymphoma, Burkitt's,Tumor, Burkitt,Tumor, Burkitt's
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006503 Hepatic Veins Veins which drain the liver. Hepatic Vein,Vein, Hepatic,Veins, Hepatic

Related Publications

W G Woods, and L P Dehner, and M E Nesbit, and W Krivit, and P F Coccia, and N K Ramsay, and T H Kim, and J H Kersey
January 1979, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
W G Woods, and L P Dehner, and M E Nesbit, and W Krivit, and P F Coccia, and N K Ramsay, and T H Kim, and J H Kersey
July 1983, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
W G Woods, and L P Dehner, and M E Nesbit, and W Krivit, and P F Coccia, and N K Ramsay, and T H Kim, and J H Kersey
April 1981, American journal of clinical pathology,
W G Woods, and L P Dehner, and M E Nesbit, and W Krivit, and P F Coccia, and N K Ramsay, and T H Kim, and J H Kersey
January 1989, Oncology nursing forum,
W G Woods, and L P Dehner, and M E Nesbit, and W Krivit, and P F Coccia, and N K Ramsay, and T H Kim, and J H Kersey
January 1994, Bone marrow transplantation,
W G Woods, and L P Dehner, and M E Nesbit, and W Krivit, and P F Coccia, and N K Ramsay, and T H Kim, and J H Kersey
May 1982, Cancer,
W G Woods, and L P Dehner, and M E Nesbit, and W Krivit, and P F Coccia, and N K Ramsay, and T H Kim, and J H Kersey
September 1983, The Nursing clinics of North America,
W G Woods, and L P Dehner, and M E Nesbit, and W Krivit, and P F Coccia, and N K Ramsay, and T H Kim, and J H Kersey
October 1999, Bone marrow transplantation,
W G Woods, and L P Dehner, and M E Nesbit, and W Krivit, and P F Coccia, and N K Ramsay, and T H Kim, and J H Kersey
January 1988, Bone marrow transplantation,
W G Woods, and L P Dehner, and M E Nesbit, and W Krivit, and P F Coccia, and N K Ramsay, and T H Kim, and J H Kersey
May 1997, Transplantation,
Copied contents to your clipboard!